HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Elon H C van Dijk Selected Research

Central Serous Chorioretinopathy

12/2022Choroidal arteriovenous anastomoses: a hypothesis for the pathogenesis of central serous chorioretinopathy and other pachychoroid disease spectrum abnormalities.
11/2022Clinical impact of the worldwide shortage of verteporfin (Visudyne®) on ophthalmic care.
10/2022Crossover to Half-Dose Photodynamic Therapy or Eplerenone in Chronic Central Serous Chorioretinopathy Patients.
7/2022Sex Hormones in Males and Females with Active Central Serous Chorioretinopathy.
2/2022Subretinal fluid morphology in chronic central serous chorioretinopathy and its relationship to treatment: a retrospective analysis on PLACE trial data.
1/2022EFFICACY OF HALF-DOSE PHOTODYNAMIC THERAPY VERSUS HIGH-DENSITY SUBTHRESHOLD MICROPULSE LASER FOR TREATING PIGMENT EPITHELIAL DETACHMENTS IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY.
1/2022Response to Letter to the Editor From Behar-Cohen et al.: The Cortisol Response of Male and Female Choroidal Endothelial Cells: Implications for Central Serous Chorioretinopathy.
1/2022Half-Dose Photodynamic Therapy Versus Eplerenone in Chronic Central Serous Chorioretinopathy (SPECTRA): A Randomized Controlled Trial.
1/2022The Cortisol Response of Male and Female Choroidal Endothelial Cells: Implications for Central Serous Chorioretinopathy.
12/2021SALIVARY ALPHA-AMYLASE LEVELS MAY CORRELATE WITH CENTRAL SEROUS CHORIORETINOPATHY ACTIVITY.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Elon H C van Dijk Research Topics

Disease

35Central Serous Chorioretinopathy
12/2022 - 09/2015
11Diabetic Retinopathy (Retinopathy, Diabetic)
01/2022 - 09/2015
3Polypoidal Choroidal Vasculopathy
11/2022 - 01/2017
3Macular Degeneration (Age-Related Maculopathy)
06/2020 - 01/2017
3Melanoma (Melanoma, Malignant)
11/2018 - 09/2015
2Neoplasms (Cancer)
01/2021 - 05/2016
2Retinal Detachment (Retinal Detachments)
01/2021 - 03/2018
1Central Nervous System Vascular Malformations (Dural Arteriovenous Fistula)
12/2022
1Cataract (Cataracts)
09/2022
1Rupture
09/2022
1Carotid-Cavernous Sinus Fistula
01/2022
1Atrophy
04/2021
1Vascular Diseases (Vascular Disease)
01/2021
1Paraneoplastic Syndromes (Paraneoplastic Syndrome)
01/2021
1Inborn Genetic Diseases (Disease, Hereditary)
01/2021
1Hemangioma (Angioma)
06/2020
1Proliferative Vitreoretinopathy
03/2018
1Uveitis
02/2018
1Uveal melanoma
09/2015

Drug/Important Bio-Agent (IBA)

191-phenyl-3,3-dimethyltriazene (PDT)IBA
11/2022 - 09/2016
9Retinaldehyde (Retinal)IBA
11/2021 - 09/2015
3Adrenal Cortex Hormones (Corticosteroids)IBA
12/2022 - 09/2016
3Verteporfin (Visudyne)FDA Link
11/2022 - 11/2018
3Indocyanine Green (Cardio-Green)FDA LinkGeneric
01/2022 - 10/2017
3Hydrocortisone (Cortisol)FDA LinkGeneric
01/2022 - 06/2020
3Fluorescein (Funduscein)FDA LinkGeneric
04/2021 - 10/2017
3Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
11/2018 - 09/2015
2Eplerenone (Inspra)FDA LinkGeneric
10/2022 - 01/2022
2Complement System Proteins (Complement)IBA
10/2018 - 01/2017
1Capsules (Microcapsules)IBA
09/2022
1Gonadal Steroid Hormones (Sex Hormones)IBA
07/2022
1Retinal Pigments (Pigments, Visual)IBA
01/2022
1Salivary alpha-AmylasesIBA
12/2021
1Indicators and Reagents (Reagents)IBA
12/2021
1GlucocorticoidsIBA
06/2020
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
06/2020
1N- (2,3- dihydroxypropyl)- 1- ((2- fluoro- 4- iodophenyl)amino)isonicotinamideIBA
11/2018
1Biomarkers (Surrogate Marker)IBA
03/2018
1AntibodiesIBA
02/2018
1Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA
01/2017
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2017
1SteroidsIBA
09/2016
1binimetinibIBA
09/2015

Therapy/Procedure

22Photochemotherapy (Photodynamic Therapy)
10/2022 - 09/2015
12Lasers (Laser)
02/2022 - 09/2015
3Therapeutics
01/2022 - 09/2016
3Slit Lamp
11/2018 - 09/2015
1Intravitreal Injections
09/2022
1Operative Surgical Procedures
03/2018
1Aftercare (After-Treatment)
09/2016